Awen Oncology
1 known investors
Awen Oncology is a drug discovery company developing first-in-class oncology therapeutics that target cancer-specific proteins found only in tumor cells, aiming for treatments with improved efficacy and fewer side effects. It combines high-throughput cell and molecular biology with computational techniques to identify novel therapeutic targets for cancer patients.
Founders & leadership
PA
Prof. Andrea BrancaleChairman, Co-Founder
DR
Dr. Ramsay McFarlaneCEO, Co-Founder
DJ
Dr. Jane WakemanCSO, Co-Founder
Investors · 1
Frequently asked questions
- What does Awen Oncology do?
- Awen Oncology is a drug discovery company developing first-in-class oncology therapeutics that target cancer-specific proteins found only in tumor cells, aiming for treatments with improved efficacy and fewer side effects. It combines high-throughput cell and molecular biology with computational techniques to identify novel therapeutic targets for cancer patients.
- Who founded Awen Oncology?
- Awen Oncology was founded by Prof. Andrea Brancale, Dr. Ramsay McFarlane, Dr. Jane Wakeman.
- Who are Awen Oncology's investors?
- Awen Oncology's investors include Start Codon.